Mosaic Family Wealth’s Adamas Pharmaceuticals ADMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-91,314
Closed -$448K 186
2021
Q3
$448K Hold
91,314
0.12% 110
2021
Q2
$482K Hold
91,314
0.14% 98
2021
Q1
$438K Sell
91,314
-493
-0.5% -$2.57K 0.13% 99
2020
Q4
$398K Sell
91,807
-550
-0.6% -$2.35K 0.13% 101
2020
Q3
$381K Sell
92,357
-640
-0.7% -$2.48K 0.14% 94
2020
Q2
$238K Buy
92,997
+1,183
+1% +$3.48K 0.1% 124
2020
Q1
$265K Buy
91,814
+500
+0.5% +$2.24K 0.13% 104
2019
Q4
$346K Hold
91,314
0.14% 102
2019
Q3
$609K Hold
91,314
0.25% 67
2019
Q2
$566K Hold
91,314
0.24% 68
2019
Q1
$649K Hold
91,314
0.26% 58
2018
Q4
$780K Hold
91,314
0.32% 45
2018
Q3
$1.05M Hold
91,314
0.43% 33
2018
Q2
$2.36M Hold
91,314
0.89% 15
2018
Q1
$2.18M Sell
91,314
-6,000
-6% -$189K 0.81% 20
2017
Q4
$3.3M Sell
97,314
-26,000
-21% -$726K 1.2% 11
2017
Q3
$2.61M Hold
123,314
1.01% 12
2017
Q2
$2.16M Hold
123,314
0.9% 14
2017
Q1
$2.16M Hold
123,314
0.93% 14
2016
Q4
$2.08M Hold
123,314
0.96% 17
2016
Q3
$2.02M Hold
123,314
0.94% 17
2016
Q2
$1.87M Hold
123,314
0.9% 19
2016
Q1
$1.78M Buy
+123,314
New +$2.08M 0.86% 22

Mosaic Family Wealth's ADMS Position: Q4 2021 in Review

Mosaic Family Wealth sold out of Adamas Pharmaceuticals (ADMS) in Q4 2021, closing a stake of 91,314 shares — an estimated $448K sold.

Mosaic Family Wealth first reported a position in ADMS in Q1 2016 and held it in 23 quarters. The position peaked at $3.3M in Q4 2017. 0 funds tracked by Wall St. Rank hold ADMS as of Q4 2021.

  • Mosaic Family Wealth reported no remaining Adamas Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Mosaic Family Wealth sold 91,314 Adamas Pharmaceuticals shares in Q4 2021, an estimated $448K.
  • Mosaic Family Wealth first reported a position in Adamas Pharmaceuticals in Q1 2016 and held it in 23 quarters.
  • Mosaic Family Wealth's Adamas Pharmaceuticals position peaked at $3.3M in Q4 2017.
  • 0 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q4 2021.

Based on Mosaic Family Wealth's 13F filing for Q4 2021, filed 25 Jan 2022.